Extract
The coronavirus disease 2019 (COVID-19) pandemic resulted in a shift in how sleep medicine was delivered. Many centres, including ours, pivoted to home studies during lockdown. Despite the subsequent reopening of sleep laboratories, many families requested to continue with home sleep studies. However, data on feasibility of home studies in children with complex comorbidities are lacking. Many centres only perform home studies on children with suspected sleep disordered breathing who are otherwise well, but emerging data indicate that they could represent a viable alternative to inpatient studies [1], including in children with comorbidities [2, 3].